Materials Today Bio,
Journal Year:
2022,
Volume and Issue:
16, P. 100358 - 100358
Published: July 12, 2022
Multi-target
Tyrosine
Kinase
Inhibitors
(MTKIs)
have
drawn
substantial
attention
in
tumor
therapy.
MTKIs
could
inhibit
cell
proliferation
and
induce
apoptosis
by
blocking
the
activity
of
tyrosine
kinase.
However,
toxicity
drug
resistance
severely
restrict
their
further
clinical
application.
The
nano
pharmaceutical
technology
based
on
has
attracted
ever-increasing
recent
years.
Researchers
deliver
through
various
types
nanocarriers
to
overcome
improve
considerably
therapeutic
efficiency.
This
review
intends
summarize
comprehensive
applications
nanoparticles
malignant
treatment.
Firstly,
mechanism
were
introduced.
Secondly,
for
delivery
outlined.
Thirdly,
combination
treatment
schemes
reversal
strategies
emphasized
outcomes
cancer
Finally,
conclusions
perspectives
summarized
guide
future
research.
Frontiers in Pharmacology,
Journal Year:
2020,
Volume and Issue:
11
Published: May 1, 2020
Curcuma
longa
is
an
important
medicinal
plant
and
a
spice
in
Asia.
Curcumin
(diferuloylmethane)
hydrophobic
bioactive
ingredient
found
rhizome
of
the
C.
longa.
It
has
drawn
immense
attention
recent
years
for
its
variety
biological
pharmacological
action.
However,
low
water
solubility,
poor
bioavailability,
rapid
metabolism
represent
major
drawbacks
successful
therapeutic
applications.
Hence,
researchers
have
attempted
to
enhance
activity
curcumin
overcome
by
efficient
delivery
systems,
particularly
nanoencapsulation.
Research
efforts
so
far
data
from
available
literature
shown
satisfactory
potential
nano
range
formulations
(Nanocurcumin),
it
increases
all
benefits
curcumin,
which
was
not
significantly
possible
earlier.
For
synthesis
nanocurcumin,
array
techniques
been
developed
each
technique
own
advantages
individual
characteristics.
The
two
most
popular
effective
are
ionic
gelation
antisolvent
precipitation.
So
far,
many
nanoformulations
delivery,
thereby
overcoming
effects.
nanoformulation
remained
at
concept
level
evidence,
thus,
several
questions
challenges
still
exist
recommend
nanocurcumin
as
promising
candidate
In
this
review,
we
discuss
on
different
implications
applications
well
status
ongoing
clinical
trials
patents.
We
also
research
gap
future
directions
needed
propose
candidate.
Nutrients,
Journal Year:
2020,
Volume and Issue:
12(9), P. 2499 - 2499
Published: Aug. 19, 2020
Curcumin,
a
lipophilic
polyphenol
contained
in
the
rhizome
of
Curcuma
longa
(turmeric),
has
been
used
for
centuries
traditional
Asian
medicine,
and
nowadays
it
is
widely
food
as
dietary
spice
worldwide.
It
received
considerable
attention
its
pharmacological
activities,
which
appear
to
act
primarily
through
anti-inflammatory
antioxidant
mechanisms.
For
this
reason,
proposed
tool
management
many
diseases,
among
are
gastrointestinal
neurological
diabetes,
several
types
cancer.
However,
pharmacology
curcumin
remains
be
elucidated;
indeed,
discrepancy
exists
between
well-documented
vitro
vivo
activities
poor
bioavailability
chemical
instability
that
should
limit
any
therapeutic
effect.
Recently,
hypothesized
could
exert
direct
regulative
effects
tract,
where
high
concentrations
have
detected
after
oral
administration.
Consequently,
might
directly
exerts
regulatory
on
gut
microbiota,
thus
explaining
paradox
low
systemic
wide
activities.
well
known
microbiota
important
roles
human
physiology,
composition
can
influenced
by
multitude
environmental
lifestyle
factors.
Accordingly,
perturbations
microbiome
profile
or
dysbiosis
key
role
disease
progression.
Interestingly,
metabolites
shown
influence
microbiota.
worth
noting
from
interaction
two
different
phenomena
arise:
regulation
intestinal
microflora
biotransformation
both
them
potentially
crucial
activity.
This
review
summarizes
most
recent
studies
topic,
highlighting
strong
connection
with
final
aim
adding
new
insight
into
potential
mechanisms
effects.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: March 4, 2022
Abstract
Colorectal
cancer
(CRC)
is
one
of
the
most
frequently
occurring
malignancy
tumors
with
a
high
morbidity
additionally,
CRC
patients
may
develop
liver
metastasis,
which
major
cause
death.
Despite
significant
advances
in
diagnostic
and
therapeutic
techniques,
survival
rate
colorectal
metastasis
(CRLM)
remains
very
low.
CRLM,
as
complex
cascade
reaction
process
involving
multiple
factors
procedures,
has
diverse
molecular
mechanisms.
In
this
review,
we
summarize
mechanisms/pathophysiology,
diagnosis,
treatment
CRLM.
We
also
focus
on
an
overview
recent
understanding
basis
CRLM
special
emphasis
tumor
microenvironment
promise
newer
targeted
therapies
for
further
improving
prognosis
patients.
Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: March 24, 2022
JAK/STAT
signaling
pathway
is
one
of
the
important
regulatory
cascades
for
myriad
cellular
processes
initiated
by
various
types
ligands
such
as
growth
factors,
hormones,
and
cytokines.
The
physiological
regulated
are
immune
regulation,
cell
proliferation,
survival,
apoptosis
hematopoiesis
myeloid
non-myeloid
cells.
Dysregulation
reported
in
immunological
disorders,
hematological
other
solid
malignancies
through
oncogenic
activation
mutations
receptors,
downstream
mediators,
associated
transcriptional
factors
STATs.
STATs
typically
have
a
dual
role
when
explored
context
cancer.
While
several
members
STAT
family
involved
malignancies,
however,
few
which
include
STAT3
STAT5
linked
to
tumor
initiation
progression.
Other
STAT1
STAT2
pivotal
antitumor
defense
maintenance
an
effective
long-term
response
evolutionarily
conserved
programs.
effects
persistent
survival;
proliferation
invasion
made
ideal
target
drug
development
cancer
therapy.
Therefore,
understanding
intricate
pathogenesis
needs
extensive
research.
A
better
functionally
redundant
roles
JAKs
may
provide
rationale
improving
existing
therapies
deleterious
on
normal
cells
identifying
novel
targets
therapeutic
intervention
malignancies.
Molecules,
Journal Year:
2021,
Volume and Issue:
26(23), P. 7109 - 7109
Published: Nov. 24, 2021
Curcumin
is
the
primary
polyphenol
in
turmeric's
curcuminoid
class.
It
has
a
wide
range
of
therapeutic
applications,
such
as
anti-inflammatory,
antioxidant,
antidiabetic,
hepatoprotective,
antibacterial,
and
anticancer
effects
against
various
cancers,
but
poor
solubility
low
bioavailability.
Objective:
To
improve
curcumin's
bioavailability,
plasma
concentration,
cellular
permeability
processes.
The
nanocurcumin
approach
over
curcumin
been
proven
appropriate
for
encapsulating
or
loading
(nanocurcumin)
to
increase
its
potential.
Conclusion:
Though
incorporating
into
form
may
be
viable
method
overcoming
intrinsic
limitations,
there
are
reasonable
concerns
regarding
toxicological
safety
once
it
enters
biological
pathways.
This
review
article
mainly
highlights
benefits
curcumin.
Journal of Cellular Physiology,
Journal Year:
2020,
Volume and Issue:
235(12), P. 9241 - 9268
Published: June 9, 2020
Abstract
Lung
cancer
is
a
main
cause
of
death
all
over
the
world
with
high
incidence
rate.
Metastasis
into
neighboring
and
distant
tissues
as
well
resistance
cells
to
chemotherapy
demand
novel
strategies
in
lung
therapy.
Curcumin
naturally
occurring
nutraceutical
compound
derived
from
Curcuma
longa
(turmeric)
that
has
great
pharmacological
effects,
such
anti‐inflammatory,
neuroprotective,
antidiabetic.
The
excellent
antitumor
activity
curcumin
led
its
extensive
application
treatment
various
cancers.
In
present
review,
we
describe
against
cancer.
affects
different
molecular
pathways
vascular
endothelial
growth
factors,
nuclear
factor‐κB
(NF‐κB),
mammalian
target
rapamycin,
PI3/Akt,
microRNAs,
long
noncoding
RNAs
also
can
induce
autophagy,
apoptosis,
cell
cycle
arrest
reduce
viability
proliferation
cells.
Notably,
supplementation
sensitizes
enhances
chemotherapy‐mediated
apoptosis.
elevate
efficacy
radiotherapy
therapy
by
targeting
signaling
pathways,
epidermal
factor
receptor
NF‐κB.
Curcumin‐loaded
nanocarriers
enhance
bioavailability,
cellular
uptake,
curcumin.
aforementioned
effects
are
comprehensively
discussed
current
review
further
direct
studies
for
applying
Nutrients,
Journal Year:
2020,
Volume and Issue:
12(3), P. 679 - 679
Published: March 2, 2020
Prostate
cancer
(PCa)
is
a
heterogeneous
disease
and
ranked
as
the
second
leading
cause
of
cancer-related
deaths
in
males
worldwide.
The
global
burden
PCa
keeps
rising
regardless
emerging
cutting-edge
technologies
for
treatment
drug
designation.
There
are
number
options
which
effectively
treating
localised
androgen-dependent
(ADPC)
through
hormonal
surgery
treatments.
However,
over
time,
these
cancerous
cells
progress
to
androgen-independent
(AIPC)
continuously
grow
despite
hormone
depletion.
At
this
particular
stage,
androgen
depletion
therapy
(ADT)
no
longer
effective
rendered
hormone-insensitive
capable
growing
absence
androgen.
AIPC
lethal
type
leads
poor
prognosis
major
contributor
death
rates.
A
natural
product-derived
compound,
curcumin
has
been
identified
pleiotropic
compound
influencing
modulating
diverse
range
molecular
targets
signalling
pathways
order
exhibit
its
medicinal
properties.
Due
such
multi-targeted
behaviour,
benefits
paramount
combating
wide
diseases
including
inflammation
disease.
Curcumin
exhibits
anti-cancer
properties
by
suppressing
growth
survival,
inflammation,
invasion,
cell
proliferation
well
possesses
ability
induce
apoptosis
malignant
cells.
In
review,
we
investigate
mechanism
multiple
receptor
(AR)
signalling,
activating
protein-1
(AP-1),
phosphatidylinositol
3-kinases/the
serine/threonine
kinase
(PI3K/Akt/mTOR),
wingless
(Wnt)/ß-catenin
nuclear
factor
kappa-B
(NF-κB),
B-cell
lymphoma
2
(Bcl-2)
cyclin
D1
implicated
development
progression
both
types
PCa,
ADPC
AIPC.
addition,
role
microRNAs
clinical
trials
on
effects
patients
were
also
reviewed.
Phytotherapy Research,
Journal Year:
2020,
Volume and Issue:
34(12), P. 3311 - 3324
Published: July 6, 2020
Abstract
Curcumin,
a
polyphenol
isolated
from
the
rhizome
of
Curcuma
longa
,
has
been
studied
because
its
antioxidant,
antimicrobial,
and
antiinflammatory
properties.
This
study
aimed
to
evaluate
effects
curcumin
on
head
neck
cancer
(HNC)
cell
lines
how
it
modulates
PI3K–AKT–mTOR
signaling
pathway.
Dose‐response
curves
for
were
established
hypopharynx
carcinoma
(FaDu),
tongue
(SCC‐9),
keratinocytes
(HaCaT)
IC
50
values
calculated.
Cell
cycle
death
investigated
through
flow
cytometry.
Cytoskeleton
organization
was
assessed
phalloidin+FITC
staining.
qPCR
array
western
blot
performed
analyze
gene
protein
expression.
Curcumin
reduced
viability
in
dose‐dependent
selective
manner,
induced
SCC‐9
cells
(necrosis/late
apoptosis:
44%
vs.
16.4%
vehicle),
arrested
at
phase
G
2
/M
FaDu
(G
:
SCC‐9—19.1%
13.4%
vehicle;
FaDu—37.8%
12.9%
vehicle).
Disorganized
cytoskeleton
altered
morphology
observed.
Furthermore,
downregulated
pathway
by
modifying
expression
key
genes
proteins.
These
findings
highlight
promising
therapeutic
potential
inhibit
HNC
growth
progression
modulate
ACS Applied Materials & Interfaces,
Journal Year:
2021,
Volume and Issue:
13(14), P. 16019 - 16035
Published: April 5, 2021
Recent
research
studies
have
shown
that
the
low
survival
rate
of
liver
cancer
is
due
to
drug
resistance
and
metastasis.
In
tumor
microenvironment
(TME),
activated
hepatic
stellate
cells
(aHSCs)
been
proven
favor
development
cancer.
Hence,
combination
therapy
dual-targeting
aHSCs
might
be
an
effective
strategy
for
treatment
this
study,
novel
multifunctional
liposomes
(CAPS-CUR/GA&Gal-Lip)
were
prepared
co-delivery
curcumin
(CUR)
capsaicin
(CAPS),
in
which
glycyrrhetinic
acid
(GA)
galactose
(Gal)
chosen
as
targeting
ligands
modify
(Lip)
To
mimic
TME,
a
HSCs+HepG2
(human
hepatoma
cell
line)
cocultured
model
was
established
antitumor
effect
vitro.
The
results
showed
that,
compared
HepG2
alone,
promoted
migration
by
upregulating
expression
P-glycoprotein
(P-gp)
Vimentin,
effectively
inhibited
CAPS-CUR/GA&Gal-Lip.
efficacy
vivo
evaluated
three
mice
models:
subcutaneous
H22
(mouse
tumor-bearing
mice,
H22+m-HSC
cell)
orthotopic
cells-bearing
mice.
CAPS-CUR/GA&Gal-Lip
exhibited
lesser
extracellular
matrix
(ECM)
deposition,
angiogenesis,
superior
with
no-
and/or
Gal-modified
Lip,
attributed
simultaneous
blocking
activation
HSCs
inhibition
metastasis
cells.
method
using
Lip
thus
potential
treatment.